Dovonex is a prescription medication approved by the Food and Drug Administration (FDA) in 1993. Dovonex is used to treat plaque psoriasis and psoriasis affecting hair and nails. Dovonex is also known by its drug name calcipotriene.
Dovonex should not be used by anyone with hypercalcemia (increased blood calcium levels), vitamin D toxicity, or allergies to calcipotriene. Dovonex may not be suitable for use by pregnant women or women who are breastfeeding.
Calcipotriene, the active ingredient in Dovonex, is a synthetic form of vitamin D. It is believed that Dovonex works in cases of psoriasis by slowing the growth of skin cells, helping reduce scaly skin and lesions.read more
How do I take it?
Dovonex is applied topically to the affected areas once or twice a day.
Dovonex should not be used on the face. Wash your hands thoroughly after applying Dovonex, and avoid getting Dovonex into your eyes, mouth, or vagina.
Inform your doctor if you are receiving phototherapy. Using phototherapy while using Dovonex may result in unwanted side effects.
Always follow your doctor’s instructions exactly when using Dovonex.
In clinical trials, approximately 50 percent of people using calcipotriene (Dovonex) experienced significant improvement in their psoriasis after eight weeks of use. Only four percent of participants experienced complete clearing of their psoriasis.
Side effects of Dovonex may include irritation, burning, redness, flaking, dry skin, itching, and worsening of psoriasis. Rarely, Dovonex may result in skin atrophy, hyperpigmentation (darkening of the skin), hypercalcemia, swollen blood vessels in the affected area, and folliculitis (infected or inflamed hair follicles).
Many drugs can cause allergic reactions that, in the most serious cases, can result in death. Seek immediate medical help if you experience signs of a severe allergic reaction such as difficulty breathing or swelling in the face, throat, eyes, lips or tong
We never share your personal information with anyone.Continue with Facebook Sign up with your email